In the EU alone it is estimated that AMR costs EUR 1.5 billion annually in healthcare costs and productivity losses4.
Antimikroobikumiresistentsuse hinnanguline kulu, mille moodustavad tervishoiukulud ja tootlikkuse vähenemine, on ainuüksi ELis 1,5 miljardit eurot aastas4.